Masahiro Mori

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Clinical features and prognosis of Miller Fisher syndrome

Masahiro Mori, Satoshi Kuwabara, Toshio Fukutake et al. · Neurology · 2001 · 412 citations

Clinical Finding, Profound Ataxia, Autoimmune Disease +12

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

Masayuki Tahara, Tomoko Oeda, Kazumasa Okada et al. · The Lancet Neurology · 2020 · 347 citations

Ocular Disease, Ophthalmology, Eye Health +5

Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7

Yasuyuki Fujimoto, Hiroyuki Itabe, Jun Sakai et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2003 · 328 citations

Lipid Analysis, Protein Function, Biochemistry +7

Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan

Kazue Ogawara, Satoshi Kuwabara, Masahiro Mori et al. · Annals of Neurology · 2000 · 325 citations